A drug being developed to combat metabolic diseases such as type 2 diabetes and Alzheimer’s disease may offer new treatment hope for people with chronic myeloid leukaemia (CML), a form of blood cancer. The new study, led by the University of Glasgow and published in Nature Communications, focused on understanding the unique role glucose plays […]
Read More… from New treatment hope for chronic myeloid leukaemia
Revolution in care of leukaemia as new treatment drug approved for cancer patients: Asciminib for Chronic myeloid leukaemia CML works differently to existing treatments, giving hope to patients who need a different approach. The charity Leukaemia Care today welcomes the news from the National Institute for Health and Care Excellence that a new cancer treatment […]
Read More… from Revolution in leukaemia care as new drug appoved